Last reviewed · How we verify

NCT07202455: ENADA

Effect of Early Neuromodulation Coupled With Rehabilitation on the Prevention of Post-stroke Pain

Not yet recruiting NA Last updated 23 December 2025
What this trial tests

NA trial testing Active tDCS in Stroke in 60 participants. Not yet recruiting.

Timeline
1 January 2026
Primary endpoint
30 April 2029
30 April 2029

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment60
Start date1 January 2026
Primary completion30 April 2029
Estimated completion30 April 2029
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Stroke or Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective clinical study to evaluate the efficacy of tDCS stimulation, coupled with conventional rehabilitation, on the development of post-stroke neuropathic pain. The study involves a double-blind, randomized, sham-controlled experimental protocol involving 2 parallel groups with patients allocated according to a Fleming design (40 patients in the active group, 20 patients in the control group). The study is aimed at sub-acute post-stroke patients. After recruitment, they will receive 10 sessions of tDCS stimulation (2mA, 20 minutes with a current on/off ramp of 0.1 mA/s). For the control group, stimulation will stop after the current ramp.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Active tDCS

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07202455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing